Skip to content
Trending
April 27, 2025Plane tickets are getting cheaper as domestic travel demand weakens September 20, 2025Steve Bannon floats idea of Bessent running both Treasury and the Fed July 12, 2025‘Superman’ snares $22.5 million in Thursday previews on way to $140 million opening August 20, 2025TJ Maxx parent company TJX beats earnings expectations, raises full-year guidance despite tariff pressure October 28, 2025The Fed has a rate cut plus a bunch of other things on its plate this week. Here’s what to expect March 13, 2025Here’s the inflation breakdown for February 2025 — in one chart September 16, 2025Bessent sees trade deal likely with China before November deadline on reciprocal tariffs November 25, 2025A third high-profile tech leader is leaving GM as part of a software-product restructuring November 12, 2025Skims valued at $5 billion after new funding round as it accelerates store expansion May 10, 2025A rare platinum Rolex is heading to auction and could fetch $1.7 million
  Thursday 9 April 2026
everydayread.net
  • HOME
  • Bitcoin
  • Business
  • Earnings
  • Economy
  • Finance
everydayread.net
everydayread.net
  • HOME
  • Bitcoin
  • Business
  • Earnings
  • Economy
  • Finance
everydayread.net
  Earnings  Walgreens tops estimates as drugstore chain cuts costs, prepares to go private
Earnings

Walgreens tops estimates as drugstore chain cuts costs, prepares to go private

AdminAdmin—April 8, 20250

More stories

Our 2 chip stocks are the portfolio’s biggest winners in one of Wall Street’s most volatile weeks

April 13, 2025

MongoDB close up 13% after company boosts guidance, cites confidence in cloud-based database service

June 17, 2025

Jeep maker Stellantis warns of a shock $2.7 billion loss as tariffs bite

July 21, 2025

Intel beats on sales in first earnings report since U.S. government became top shareholder

October 26, 2025

A sign for US drugstore chain Walgreens is displayed outside its store in New York City on March 7, 2025.

Angela Weiss | AFP | Getty Images

Walgreens on Tuesday reported fiscal second-quarter earnings and revenue that topped expectations, as the retail drugstore giant benefits from cost cuts and prepares to go private.

The company is in the process of being taken private by Sycamore Partners in a deal that is expected to close in the fourth quarter of this year.

Here’s what Walgreens reported for the three-month period ended Feb. 28 compared with what Wall Street was expecting, based on a survey of analysts by LSEG:

  • Earnings per share: 63 cents adjusted vs. 53 cents expected
  • Revenue: $38.59 billion vs. $38 billion expected

This story is developing. Please check back for updates.

Fake job seekers are flooding U.S. companies that are hiring for remote positions, tech CEOs say
CEOs think the U.S. is ‘probably in a recession right now,’ says BlackRock’s Larry Fink
Related posts
  • Related posts
  • More from author
Earnings

Nike tops earnings estimates but shares fall as China sales plunge, tariffs hit profits

December 18, 20250
Earnings

Salesforce’s raised guidance lifts the stock but doesn’t change our rating

December 17, 20250
Earnings

Oracle plummets 11% on weak revenue, pushing down AI stocks like Nvidia and CoreWeave

December 16, 20250
Load more
Read also
Finance

Visa says new AI shopping tool has helped customers with hundreds of transactions

December 18, 20250
Economy

Trust these numbers? Economists see a lot of flaws in delayed CPI report showing downward inflation

December 18, 20250
Earnings

Nike tops earnings estimates but shares fall as China sales plunge, tariffs hit profits

December 18, 20250
Business

American Airlines no longer lets basic economy flyers earn miles

December 18, 20250
Finance

Billionaire fund manager Ron Baron praises beaten-up financial stock whose new CEO he compares to Jamie Dimon

December 17, 20250
Economy

Watch Fed Governor Christopher Waller speak on interest rates and the race to succeed Powell

December 17, 20250
Load more
    © 2022, All Rights Reserved.
    • About Us
    • Advertise With Us
    • Contact Us
    • Disclaimer
    • Cookie Law
    • Privacy Policy
    • Terms & Conditions